Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China · Delayed Price · Currency is CNY 33.26
-0.73 (-2.15%)
Last updated: Sep 23, 2025, 10:15 AM CST
Enwei Pharmaceutical Market Cap
Enwei Pharmaceutical has a market cap or net worth of 3.19 billion as of September 26, 2025. Its market cap has increased by 48.05% in one year.
Market Cap
3.19B
Enterprise Value
2.84B
Revenue
873.20M
Ranking
n/a
PE Ratio
54.60
Stock Price
33.26
Market Cap Chart
Since September 21, 2022, Enwei Pharmaceutical's market cap has increased from 3.07B to 3.19B, an increase of 4.14%. That is a compound annual growth rate of 1.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 3.19B | 38.43% |
| Dec 31, 2024 | 2.31B | -20.75% |
| Dec 29, 2023 | 2.91B | 4.40% |
| Dec 30, 2022 | 2.79B | -9.08% |
| Sep 21, 2022 | 3.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 467.24B |
| WuXi AppTec | 299.67B |
| Shenzhen Mindray Bio-Medical Electronics | 288.50B |
| Sichuan Biokin Pharmaceutical | 149.53B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.01B |
| Shanghai United Imaging Healthcare | 118.35B |
| Aier Eye Hospital Group | 114.80B |
| Yunnan Baiyao Group Co.,Ltd | 101.90B |